Other news
LinkedIn post ESRR2024
š¢ Important update on EU #GMP Annex 1 at #ESRR2024! The revised EU GMP Annex 1, effecti...
Upcoming event
From October 15 to October 19, Radboud translational medicine will attend the 29th annual congress o...
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany
ABX has received marketing authorisation for the radiotracer RadeluminĀ® in Germany! This marks the 8...
First liver cancer patient treated with microspheres irradiated in TU Delft
Radboud Translational Medicine will perform the dispensing of below product. The production and dis...
Interested in a collaboration?
Contact us to discuss the possibilities.